EZH2 and neoplasm: Acts as a tumor suppressor by blocking TCA cycle regulation. Overexpression decreases cell viability through inhibition of enhancer of zest homolog 2 (EZH2) transcription by interacting with E2F4, resulting in increased expression of miR101.